Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy

We compared the short-term outcomes between 3-monthly aflibercept and brolucizumab injections for treatment-naïve polypoidal choroidal vasculopathy (PCV). A total of 52 eyes were included. Patients received 3 monthly intravitreal aflibercept (<i>n</i> = 38) or intravitreal brolucizumab (<i>n</i> = 1...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yoshiko Fukuda, Yoichi Sakurada, Mio Matsubara, Yuka Hasebe, Atsushi Sugiyama, Wataru Kikushima, Kenji Kashiwagi
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-09-01
Col·lecció:	Biomedicines
Matèries:	polypoidal choroidal vasculopathy brolucizumab aflibercept intraocular inflammation resolution of polypoidal lesion(s)
Accés en línia:	https://www.mdpi.com/2227-9059/9/9/1164
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!